ATE355067T1 - 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation - Google Patents

15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation

Info

Publication number
ATE355067T1
ATE355067T1 AT02720623T AT02720623T ATE355067T1 AT E355067 T1 ATE355067 T1 AT E355067T1 AT 02720623 T AT02720623 T AT 02720623T AT 02720623 T AT02720623 T AT 02720623T AT E355067 T1 ATE355067 T1 AT E355067T1
Authority
AT
Austria
Prior art keywords
prostaglandins
keto
drug
treatment
induced constipation
Prior art date
Application number
AT02720623T
Other languages
German (de)
English (en)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23104042&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE355067(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sucampo Ag filed Critical Sucampo Ag
Application granted granted Critical
Publication of ATE355067T1 publication Critical patent/ATE355067T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02720623T 2001-05-02 2002-04-26 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation ATE355067T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28772001P 2001-05-02 2001-05-02

Publications (1)

Publication Number Publication Date
ATE355067T1 true ATE355067T1 (de) 2006-03-15

Family

ID=23104042

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02720623T ATE355067T1 (de) 2001-05-02 2002-04-26 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation

Country Status (19)

Country Link
US (1) US6982283B2 (https=)
EP (1) EP1392318B1 (https=)
JP (1) JP4332353B2 (https=)
KR (1) KR100886598B1 (https=)
CN (1) CN1522147B (https=)
AR (2) AR035237A1 (https=)
AT (1) ATE355067T1 (https=)
AU (1) AU2002251554B2 (https=)
BR (1) BR0209327A (https=)
CA (1) CA2444103C (https=)
DE (1) DE60218451T2 (https=)
DK (1) DK1392318T3 (https=)
ES (1) ES2282408T3 (https=)
MX (1) MXPA03010019A (https=)
NO (1) NO335143B1 (https=)
NZ (1) NZ529187A (https=)
PT (1) PT1392318E (https=)
TW (1) TWI302100B (https=)
WO (1) WO2002089812A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1420794B1 (en) 2001-08-31 2017-12-27 Sucampo AG Prostaglandin analogs as chloride channel openers
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
TWI263505B (en) 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener
NZ539582A (en) * 2002-10-23 2007-07-27 Sucampo Ag Prostaglandin compounds for the treatment of obesity
EP1575596B1 (en) * 2002-12-27 2016-06-22 Sucampo AG Derivatives of prostaglandins for treating irritable bowel syndrome and/or functional dyspepsia
TWI387454B (zh) * 2004-09-02 2013-03-01 蘇坎波公司 治療胃腸道疾病之方法及組成物
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8524731B2 (en) * 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
ES2714198T3 (es) * 2005-03-07 2019-05-27 Univ Chicago Uso de antagonistas opioideos para atenuar la proliferación y la migración de células endoteliales
RU2468800C2 (ru) * 2005-04-12 2012-12-10 Сукампо Аг Комбинированное применение производного простагландина и ингибитора протонового насоса для лечения желудочно-кишечных заболеваний
US20090030072A1 (en) * 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
US9044510B2 (en) 2007-11-01 2015-06-02 Washington University Compositions and methods for treating pruritus
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
US8957024B2 (en) 2011-07-27 2015-02-17 Washington University Composition and methods for reducing opioid-induced pruritus
KR20140052389A (ko) 2012-10-24 2014-05-07 주식회사 아리바이오 해양 심층수 또는 염지하수로부터 제조된 고경도의 미네랄 워터를 포함하는 변비 예방, 개선 또는 치료용 조성물
US20140116916A1 (en) 2012-10-31 2014-05-01 2294719 Ontario Limited Therapy for Constipation
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
CN105777601A (zh) * 2014-12-26 2016-07-20 中国人民解放军第二军医大学 一种前列地尔衍生物及其药物制剂
AU2017241904A1 (en) * 2016-03-29 2018-10-18 Colonaryconcepts Llc Formulations for treating constipation
JP6957610B2 (ja) * 2016-10-06 2021-11-02 スキャンポ・アーゲーＳｕｃａｍｐｏ ＡＧ 医薬品用途のための多層ビーズ

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1581886A (en) * 1977-05-26 1980-12-31 May & Baker Ltd Prostanol derivatives
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5317032A (en) 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
ES2051862T3 (es) * 1987-10-02 1994-07-01 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para producir un medicamento que tiene un efecto catartico.
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
TW224942B (https=) 1990-04-04 1994-06-11 Adka Ueno Kk
ATE174221T1 (de) * 1990-05-01 1998-12-15 R Tech Ueno Ltd Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
WO1997047595A1 (en) 1996-06-10 1997-12-18 R-Tech Ueno, Ltd. Endothelin antagonist
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
ATE387204T1 (de) * 2001-05-18 2008-03-15 Sucampo Ag Zusammensetzung mit induzierendem kathartischen effekt

Also Published As

Publication number Publication date
CA2444103A1 (en) 2002-11-14
WO2002089812A1 (en) 2002-11-14
CN1522147A (zh) 2004-08-18
TWI302100B (en) 2008-10-21
JP4332353B2 (ja) 2009-09-16
KR100886598B1 (ko) 2009-03-05
ES2282408T3 (es) 2007-10-16
AU2002251554B2 (en) 2007-05-24
NO20034864D0 (no) 2003-10-31
US20030073746A1 (en) 2003-04-17
PT1392318E (pt) 2007-05-31
MXPA03010019A (es) 2004-02-12
CN1522147B (zh) 2010-05-12
US6982283B2 (en) 2006-01-03
NZ529187A (en) 2005-10-28
CA2444103C (en) 2010-06-08
AR035237A1 (es) 2004-05-05
EP1392318B1 (en) 2007-02-28
BR0209327A (pt) 2004-07-20
NO335143B1 (no) 2014-09-29
DE60218451T2 (de) 2007-11-08
AR100696A2 (es) 2016-10-26
NO20034864L (no) 2003-12-23
DE60218451D1 (de) 2007-04-12
DK1392318T3 (da) 2007-06-25
EP1392318A1 (en) 2004-03-03
JP2004527567A (ja) 2004-09-09
KR20040008168A (ko) 2004-01-28

Similar Documents

Publication Publication Date Title
ATE355067T1 (de) 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60028358D1 (de) Hmg1 antagonisten zur behandlung von entzündungen
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20035522D0 (no) Kinuklidin-substituerte multisykliske heteroaryler for behandling av sykdom
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE50201891D1 (de) Verfahren zur herstellung von 1-octen
NO20040253L (no) Fremgangsmater for behandling av leverfibroser
DE502004010131D1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
ATE312104T1 (de) Verbindungen zur behandlung von beeinträchtigten fundischen entspannung
DE50210487D1 (de) Verfahren zur Herstellung von 1-Amino-4-hydroxyanthrachinonen
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
ATE250611T1 (de) Pyranoindole zur glaukombehandlung
NO20030717L (no) Forbindelser for behandling av avhengighetsforstyrrelser
DE60005685D1 (de) Oxazinocarbazole zur behandlung von cns-erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1392318

Country of ref document: EP